Anti-Hemophilic Factor VIII Concentrate from Germany
A lyophilized concentrate of coagulation Factor VIII derived from human plasma, used therapeutically for hemophilia A treatment. This blood fraction is prepared for therapeutic use, falling under tariff item 3002.90.00 as 'Other' cell cultures.
Duty Rate — Germany → Canada
0%
Import Tips
• Provide documentation of the human plasma source and therapeutic use for CBSA
• Ensure the product is not classified as a medicament if put up for retail sale
• Verify that it is not a waste pharmaceutical, which would fall under heading 30.06